Concurrently, there is rising market demand for plas- tic products treated with antimicrobial additives for applications in packaging, automotive, consumer goods, medical and healthcare, building and construction, sport- ing goods, and electronics markets. To reduce the incidence of device-associated infections, antimicrobial technologies have been utilized in a variety of ways ranging from bulk-imbedded additives to sur- face grafting techniques.[13,14] In particular, silver-based additive technologies are frequently explored for healthcare applications due to their favorable toxicological profiles and broader regulatory approvals, while silver nanoparticles with controlled, long-term release profiles continue to be a very active and promising area of biomedi- cal research.[15-19] In textile segments such as sports active- wear, biocides are used to prevent the growth of odor- causing bacteria from perspiration.[20,21] Additionally, high-end recreational products such as boats utilize bio- cides to preserve the aesthetics of PVC products used for seat covers since bacterial growth may lead to pink staining caused by specific bacterial metabolites.[22,23] With respect to the mechanism of action, many antimicrobial products work by attacking enzymes common to a variety of microbes, interfering with membrane transport processes (e.g., importing environmental copper into the cells) as well as interfering with iron metabolism pathways.[24,25] Herein, an assortment of both rigid and flexible resins/ compounds will be evaluated for susceptibility to determine whether particular resin chemistries or compounds are inherently vulnerable to microbial growth and subsequent degradation or other deleterious effects. Vandendaele, Medi- cal and Healthcare Textiles.

FIBER COLORANTS & ADDITIVES TYPICAL APPLICATIONS • Clothing: apparel, hosiery, sportswear, shoes • Home: upholstery, carpets, furniture, curtains • Outdoor: awnings, umbrellas, automobile/boat covers • Automotive: seat covers, floor systems, headliners, side panels, tyrecords • Technical: ropes, belts, luggage, monofilament fishing yarn, artificial grass • Healthcare & Sanitary: diapers, hygiene products, face masks, surgery gowns, wound dressing • Building & Construction: filtration systems, flooring, padding, geotextiles From the clothes we wear to the upholstery in the cars we drive, color plays a major role in driving consumer appeal.

如需深入了解Mevopur的用途和限制，请参见 HYPERLINK "http://www.avient.com/healthcare-use-limitations-mevopur-products" www.avient.com/healthcareuselimitationsmevopurproducts，或联系您的埃万特销售代表。

From healthcare to transportation to packaging, and ever ything in between, we help our customers meet their product design and sustainability goals. As the focus on sustainability continues to grow in the healthcare industr y, Avient has continued to evolve our portfolio to meet our customers’ needs. Our portfolio is designed to help our customers overcome healthcare challenges with durable, lightweight, eco-conscious and lower carbon footprint materials.

Organic revenues increased 17% to $1.16 billion driven by strong demand across all segments, with the most significant growth in healthcare and consumer end markets The company cited strong demand for healthcare (up 22%) and consumer products (up 24%) as organic revenue increased 17% to Demand conditions were robust in the quarter, in particular for composite technologies and new business gains in healthcare applications.

PET is shatter proof and not prone to breakage, making it ideal for food, beverage and healthcare products.

PolyOne Corporation Page 4 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 20 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Goal of $2.50 adjusted EPS by 2015, three times the EPS generated in 2011 of $0.82 • Drive double digit operating income and adjusted EPS growth PolyOne Corporation Page 5 Building & Construction 13% Industrial 12% Transportation 18% Wire & Cable 9% Packaging 16% Consumer 10% HealthCare 11% Appliance 6% Electronics & Electrical 5% 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% $13 $31 $46 $46 $92 $96 $122 $195 $0 $50 $100 $150 $200 2006 2007 2008 2009 2010 2011 2012 2013 Specialty Operating Income PolyOne Corporation Page 6 Old PolyOne *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2014 YTD 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $191M Target Mix Shift Highlights Specialty Transformation Transformation 2015 Target PolyOne Corporation Page 7 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence PolyOne Corporation Page 8 Strategy and Execution Drive Results $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 '06 '07 '08 '09 '10 '11 '12 '13 ‘06-‘13 EPS CAGR = 41% EPS Share Price vs.

Chemically Resistant Polymers for Next Generation Healthcare and Consumer Products Thermoplastic Elastomers for Healthcare Overview Healthcare

for the last twelve months, includes specialty technologies and solutions for high-growth global end markets, such as consumer, packaging, and healthcare. 

The Specialty Engineered Materials segment in particular has exceeded our previous expectations, driven by strong performance in our composites platform and new business wins in healthcare."